Suppr超能文献

[洋地黄苷在严重室内传导障碍中的应用]

[Use of digitalis glycosides in severe disorders of intra-ventricular conduction].

作者信息

Ollagnier J, Denizeau J P, Chiche P

出版信息

Arch Mal Coeur Vaiss. 1978 Oct;71(10):1129-34.

PMID:104685
Abstract

The use of digitalis in severe disorders of intra-ventricular conduction is debatable, and some consider it contra-indicated. Once it had been shown that the latter attitude is at best based on contraversial theoretical arguments, two types of study were undertaken: 1. Nine patients with bilateral bundle branch block had intracavitary recordings made of the HV interval both before and for one hour after the administration of lanatoside C (0.8 to 1.6 mg). In no case was this interval found to be increased, indicating that there was no increase in the original conduction defect. 2. Thirty four patients with complete right bundle branch block and associated left antero-superior hemiblock were digitalised, and followed up for an average of 16 months; only 2 complete atrio-ventricular blocks occurred (5.9%). The risk of complete atrio-ventribular block occurring within a year (4.5% in our series) does not differ significantly from that in an identical control group of 38 patients with the same conduction defect, but who were not digitalised (6%). Three patients had a therapeutic overdose of digitalis with no observed increase in their atrio-ventricular block. The authors conclude that it is perfectly in order to digitalise a patient with a severe intra-ventricular conduction defect.

摘要

洋地黄在严重室内传导障碍中的应用存在争议,一些人认为它是禁忌的。一旦表明后一种态度充其量是基于有争议的理论观点,便开展了两类研究:1. 9例双侧束支传导阻滞患者在静脉注射毛花苷C(0.8至1.6毫克)之前及之后1小时进行了心腔内希氏束电图记录。在所有病例中均未发现该间期延长,这表明原有传导障碍并未加重。2. 34例完全性右束支传导阻滞合并左前上半阻滞患者接受洋地黄化,并平均随访16个月;仅发生2例完全性房室传导阻滞(5.9%)。在一年内发生完全性房室传导阻滞的风险(在我们的系列研究中为4.5%)与38例具有相同传导缺陷但未接受洋地黄化的对照患者组(6%)相比,差异无统计学意义。3例患者洋地黄治疗过量,但未观察到房室传导阻滞加重。作者得出结论,对于有严重室内传导缺陷的患者进行洋地黄化是完全合理的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验